Trial
NCT02065466
Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Arizona
Collaborators
—
Condition
Metastatic Melanoma
Intervention
nab-paclitaxel
Why stopped
lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-04-21